Neocolipor (--) - Suspension for injection
Neocolipor (--) - Suspension for injection
Not authorised
- Escherichia coli, fimbrial adhesin F6
- Escherichia coli, fimbrial adhesin F5
- Escherichia coli, fimbrial adhesin F41
- Escherichia coli, fimbrial adhesin F4 (F4ab, F4ac, F4ad)
Product identification
Medicine name:
Neocolipor (--) - Suspension for injection
Active substance:
- Escherichia coli, fimbrial adhesin F6
- Escherichia coli, fimbrial adhesin F5
- Escherichia coli, fimbrial adhesin F41
- Escherichia coli, fimbrial adhesin F4 (F4ab, F4ac, F4ad)
Target species:
This information is not available for this product.
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Escherichia coli, fimbrial adhesin F6Presentation_strength:At least 1.4 SA U. Reference:Hse Index:0
-
Escherichia coli, fimbrial adhesin F5Presentation_strength:At least 1.7 SA U. Reference:Hse Index:1
-
Escherichia coli, fimbrial adhesin F41Presentation_strength:At least 1.7 SA U. Reference:Hse Index:2
-
Escherichia coli, fimbrial adhesin F4 (F4ab, F4ac, F4ad)Presentation_strength:At least 2.1 SA U. Reference:Hse Index:3
Pharmaceutical form:
-
Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AB02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Liechtenstein
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone) - Council Directive 81/851/EEC
Marketing authorisation holder:
- Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 31/01/2025
Bulgarian (PDF)
Published on: 31/01/2025
Croatian (PDF)
Published on: 31/01/2025
Czech (PDF)
Published on: 31/01/2025
Danish (PDF)
Published on: 31/01/2025
Dutch (PDF)
Published on: 31/01/2025
Estonian (PDF)
Published on: 31/01/2025
Finnish (PDF)
Published on: 31/01/2025
French (PDF)
Published on: 31/01/2025
German (PDF)
Published on: 31/01/2025
Greek (PDF)
Published on: 31/01/2025
Hungarian (PDF)
Published on: 31/01/2025
Icelandic (PDF)
Published on: 31/01/2025
Italian (PDF)
Published on: 31/01/2025
Latvian (PDF)
Published on: 31/01/2025
Lithuanian (PDF)
Published on: 31/01/2025
Maltese (PDF)
Published on: 31/01/2025
Norwegian (PDF)
Published on: 31/01/2025
Polish (PDF)
Published on: 31/01/2025
Portuguese (PDF)
Published on: 31/01/2025
Romanian (PDF)
Published on: 31/01/2025
Slovak (PDF)
Published on: 31/01/2025
Slovenian (PDF)
Published on: 31/01/2025
Spanish (PDF)
Published on: 31/01/2025
Swedish (PDF)
Published on: 31/01/2025
How useful was this page?:
